VRS
RAPT

Virginia Retirement Systems’s RAPT Therapeutics RAPT Stock Holding History

Virginia Retirement Systems’s Portfolio RAPT Stock Details RAPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$171K Sell
1,288
-350
-21% -$57.1K ﹤0.01% 890
2023
Q2 		$245K Buy
+1,638
New +$255K ﹤0.01% 888

Other funds holding RAPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Virginia Retirement Systems's RAPT Position: Q3 2023 in Review

Virginia Retirement Systems reduced its RAPT Therapeutics (RAPT) stake by 21% in Q3 2023, selling an estimated $57.1K and leaving 1,288 shares worth $171K. The position accounts for ﹤0.01% of the portfolio, ranked #890.

Virginia Retirement Systems first reported a position in RAPT in Q2 2023 and has held it in 2 quarters since. The position peaked at $245K in Q2 2023. 96 funds tracked by Wall St. Rank hold RAPT as of Q3 2023.

  • Virginia Retirement Systems held 1,288 shares of RAPT Therapeutics worth $171K as of Q3 2023.
  • Virginia Retirement Systems sold 350 RAPT Therapeutics shares in Q3 2023, an estimated $57.1K.
  • RAPT Therapeutics made up ﹤0.01% of Virginia Retirement Systems's portfolio in Q3 2023, its #890 holding.
  • Virginia Retirement Systems first reported a position in RAPT Therapeutics in Q2 2023 and has held it in 2 quarters since.
  • Virginia Retirement Systems's RAPT Therapeutics position peaked at $245K in Q2 2023.
  • 96 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q3 2023.

Based on Virginia Retirement Systems's 13F filing for Q3 2023, filed 2 Jan 2024.